KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 98 filers reported holding KALVISTA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $12,580,284 | +76.3% | 1,600,545 | +51.6% | 2.47% | +76.6% |
| Q4 2022 | $7,137,215 | -68.3% | 1,055,801 | -32.0% | 1.40% | -74.2% |
| Q3 2022 | $22,515,000 | +49.6% | 1,551,719 | +1.4% | 5.42% | +50.1% |
| Q2 2022 | $15,055,000 | +16.8% | 1,530,000 | +75.0% | 3.61% | +16.0% |
| Q1 2022 | $12,886,000 | +136.4% | 874,197 | +112.2% | 3.11% | +157.1% |
| Q4 2021 | $5,450,000 | – | 411,937 | – | 1.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,719,576 | $25,679,000 | 12.37% |
| Vivo Capital, LLC | 1,618,296 | $30,731,000 | 1.37% |
| Opaleye Management Inc. | 470,203 | $8,929,000 | 1.17% |
| INTERWEST VENTURE MANAGEMENT CO | 388,766 | $7,383,000 | 0.92% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 177,433 | $3,369,000 | 0.92% |
| Ikarian Capital, LLC | 1,063,961 | $20,204,000 | 0.89% |
| Ghost Tree Capital, LLC | 200,000 | $3,798,000 | 0.85% |
| Logos Global Management LP | 490,000 | $9,305,000 | 0.80% |
| Eventide Asset Management | 1,680,000 | $31,903,000 | 0.49% |
| Affinity Asset Advisors, LLC | 45,000 | $855,000 | 0.45% |